January 17, 2019 | English | عربي
Add to Twitter
R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide
• The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids

• Industry moves beyond compliance and reaffirms its commitment to ensuring an ethical framework as a way to increase integrity and trust

• Industry presents new Code to patients and healthcare professionals